Trevena, Inc. (NASDAQ: TRVN) today announced publication of APOLLO-1 (Phase 3) results in The Journal of Pain Research on the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE